FIELD: biotechnology.
SUBSTANCE: disclosed is a modulating polynucleotide for modulating gene expression in a cell.
EFFECT: invention can be applied in medicine.
17 cl, 13 dwg, 19 tbl, 19 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MODULATING POLYNUCLEOTIDES | 2015 |
|
RU2749882C2 |
| MIRNA STRUCTURES WITH HIGH ACTIVITY AND REDUCED EXPOSURE OUTSIDE THE TARGET | 2016 |
|
RU2788030C2 |
| MODIFIED OLIGONUCLEOTIDES AND METHODS OF THEIR USE | 2017 |
|
RU2802836C2 |
| AGENTS FOR RNAi, COMPOSITIONS AND METHODS OF THEIR USE FOR THE TREATMENT OF DISEASES ASSOCIATED WITH TRANSTHYRETIN (TTR) | 2012 |
|
RU2804776C2 |
| DELIVERY, USE AND USE IN THERAPY OF CRISPR-CAS SYSTEMS AND COMPOSITIONS FOR TARGETED ACTION ON DISORDERS AND DISEASES USING VIRAL COMPONENTS | 2014 |
|
RU2716421C2 |
| GENE EDITING USING MODIFIED CLOSED-END DNA (ceDNA) | 2018 |
|
RU2811724C2 |
| CLOSED-CIRCULAR DNA (CCDNA) AND USE IN METHODS FOR REDUCING IMMUNE RESPONSE ASSOCIATED WITH GENE THERAPY OR NUCLEIC ACID THERAPY | 2020 |
|
RU2829367C2 |
| MODIFIED CLOSED-ENDED DNA (scDNA) | 2018 |
|
RU2800026C2 |
| MODIFIED CLOSED CIRCULAR DNA (CCDNA) CONTAINING SYMMETRIC MODIFIED INVERTED END REPEATED SEQUENCES | 2019 |
|
RU2816963C2 |
| COMPOSITIONS AND METHODS FOR INHIBITION OF PROTEOLYTIC PATH OF ARGININE/N-DEGRON | 2020 |
|
RU2787841C2 |
